127 related articles for article (PubMed ID: 9298275)
21. Medulloblastoma: a critical approach to the management on the basis of 12 years of experience.
Colangelo M; Daniele B; Ruggiero R; Buonaguro A; Ambrosio A
Childs Nerv Syst; 1987; 3(2):81-4. PubMed ID: 3621232
[TBL] [Abstract][Full Text] [Related]
22. M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided.
Bouffet E; Bernard JL; Frappaz D; Gentet JC; Roche H; Tron P; Carrie C; Raybaud C; Joannard A; Lapras C
Int J Radiat Oncol Biol Phys; 1992; 24(1):79-85. PubMed ID: 1512166
[TBL] [Abstract][Full Text] [Related]
23. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
Massimino M; Gandola L; Cefalo G; Lasio G; Riva D; Fossati-Bellani F; Gianni MC; Luksch R; Tesoro-Tess JD; Lombardi F
Childs Nerv Syst; 2000 Jan; 16(1):15-20. PubMed ID: 10672424
[TBL] [Abstract][Full Text] [Related]
24. Medulloblastoma.
Zhang R; Zhou L
Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525
[TBL] [Abstract][Full Text] [Related]
25. Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003.
Kombogiorgas D; Sgouros S; Walsh AR; Hockley AD; Stevens M; Grundy R; Peet A; English M; Spooner D
Childs Nerv Syst; 2007 Apr; 23(4):399-405. PubMed ID: 17119978
[TBL] [Abstract][Full Text] [Related]
26. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
27. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
28. [High-dose chemotherapy in relapse of medulloblastoma in young children].
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
[TBL] [Abstract][Full Text] [Related]
29. Adult medulloblastoma: clinical profile and treatment results of 18 patients.
Menon G; Krishnakumar K; Nair S
J Clin Neurosci; 2008 Feb; 15(2):122-6. PubMed ID: 18078755
[TBL] [Abstract][Full Text] [Related]
30. Medulloblastoma: survival and late recurrence after the Collins' risk period.
Nishio S; Morioka T; Takeshita I; Fukui M
Neurosurg Rev; 1997; 20(4):245-9. PubMed ID: 9457719
[TBL] [Abstract][Full Text] [Related]
31. Medulloblastoma in adults: clinical characteristics and treatment.
Brandes AA; Palmisano V; Monfardini S
Cancer Treat Rev; 1999 Feb; 25(1):3-12. PubMed ID: 10212586
[TBL] [Abstract][Full Text] [Related]
32. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.
Carrie C; Lasset C; Alapetite C; Haie-Meder C; Hoffstetter S; Demaille MC; Kerr C; Wagner JP; Lagrange JL; Maire JP
Cancer; 1994 Oct; 74(8):2352-60. PubMed ID: 7922986
[TBL] [Abstract][Full Text] [Related]
33. Infants with medulloblastoma: a single institution review of survival.
Geyer R; Levy M; Berger MS; Milstein J; Griffin B; Bleyer WA
Neurosurgery; 1991 Nov; 29(5):707-10; discussion 710-1. PubMed ID: 1961400
[TBL] [Abstract][Full Text] [Related]
34. Metastatic medulloblastoma: the experience of the French Cooperative M7 Group.
Bouffet E; Gentet JC; Doz F; Tron P; Roche H; Plantaz D; Thyss A; Stephan JL; Lasset C; Carrie C
Eur J Cancer; 1994; 30A(10):1478-83. PubMed ID: 7833106
[TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
36. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD
Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
[TBL] [Abstract][Full Text] [Related]
37. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
38. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
39. [Medulloblastoma: improved survival in recent decades. Unicentric experience].
Igual Estellés L; Berlanga Charriel P; Cañete Nieto A
An Pediatr (Barc); 2017 Jan; 86(1):4-10. PubMed ID: 27068068
[TBL] [Abstract][Full Text] [Related]
40. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
